Structural mechanism of synergistic activation of Aurora kinase B/C by phosphorylated INCENP

por Abdul Azeez, Kamal R., Chatterjee, Sneha, Yu, Channing, Golub, Todd R., Sobott, Frank, Elkins, Jonathan M.
Publicado 2019

Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo

por Yu, Channing, Cantor, Alan B., Yang, Haidi, Browne, Carol, Wells, Richard A., Fujiwara, Yuko, Orkin, Stuart H.
Publicado 2002

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

por Serrano, César, Mariño-Enríquez, Adrián, Tao, Derrick L., Ketzer, Julia, Eilers, Grant, Zhu, Meijun, Yu, Channing, Mannan, Aristotle M., Rubin, Brian P., Demetri, George D., Raut, Chandrajit P., Presnell, Ajia, McKinley, Arin, Heinrich, Michael C., Czaplinski, Jeffrey T., Sicinska, Ewa, Bauer, Sebastian, George, Suzanne, Fletcher, Jonathan A.
Publicado 2019

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

por Serrano, César, Mariño-Enríquez, Adrián, Tao, Derrick L., Ketzer, Julia, Eilers, Grant, Zhu, Meijun, Yu, Channing, Mannan, Aristotle M., Rubin, Brian P., Demetri, George D., Raut, Chandrajit P., Presnell, Ajia, McKinley, Arin, Heinrich, Michael C., Czaplinski, Jeffrey T., Sicinska, Ewa, Bauer, Sebastian, George, Suzanne, Fletcher, Jonathan A.
Publicado 2019

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

por Jänne, Pasi A., Baik, Christina, Su, Wu-Chou, Johnson, Melissa L., Hayashi, Hidetoshi, Nishio, Makoto, Kim, Dong-Wan, Koczywas, Marianna, Gold, Kathryn A., Steuer, Conor E., Murakami, Haruyasu, Yang, James Chih-Hsin, Kim, Sang-We, Vigliotti, Michele, Shi, Rong, Qi, Zhenhao, Qiu, Yang, Zhao, Lihui, Sternberg, David, Yu, Channing, Yu, Helena A.
Publicado 2022

High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

por Yu, Channing, Mannan, Aristotle M., Yvone, Griselda Metta, Ross, Kenneth N., Zhang, Yan-Ling, Marton, Melissa A., Taylor, Bradley R., Crenshaw, Andrew, Gould, Joshua Z., Tamayo, Pablo, Weir, Barbara A., Tsherniak, Aviad, Wong, Bang, Garraway, Levi A., Shamji, Alykhan F., Palmer, Michelle A., Foley, Michael A., Winckler, Wendy, Schreiber, Stuart L., Kung, Andrew L., Golub, Todd R.
Publicado 2016